(Q44134896)

30 November 2017

A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus (English)

1 reference

30 November 2017

1 reference

1

H P Chase

1 reference

30 November 2017

N Butler-Simon

2

1 reference

30 November 2017

M McDuffie

4

1 reference

30 November 2017

S L Hoops

5

1 reference

30 November 2017

D O'Brien

6

1 reference

30 November 2017

S Garg

3

1 reference

30 November 2017

1 July 1990

1 reference

30 November 2017

1 reference

30 November 2017

33

1 reference

30 November 2017

444-446

1 reference

30 November 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00404097

30 November 2017

0 references

cites work

Medical care patterns at the onset of insulin-dependent diabetes mellitus: association with severity and subsequent complications

1 reference

12 December 2020

Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis

1 reference

12 December 2020

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

1 reference

12 December 2020

Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors

1 reference

12 December 2020

Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice

1 reference

12 December 2020

Mechanisms of streptozotocin- and alloxan-induced damage in rat B cells

1 reference

12 December 2020

Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) Mice

1 reference

12 December 2020

Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Nicotinamide may extend remission phase in insulin-dependent diabetes

1 reference

12 December 2020

Nicotinamide increases C-peptide secretion in patients with recent onset type 1 diabetes

1 reference

12 December 2020

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1 reference

12 December 2020

Progress toward standardization of cytoplasmic islet cell-antibody assay

1 reference

12 December 2020

Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity

1 reference

12 December 2020

Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00404097

1 reference

30 November 2017

1 reference